advancing-precision Product Portfolio

Admera’s Portfolio employs state-of-the-art genomics
technology, allowing for rapid screening of multiple genes
in parallel. All results are delivered in an actionable report,
allowing physicians to provide personalized healthcare to
their patients, based on their unique and specific needs.

Admera’s Product Portfolio

PGxOne_Plus_Test_Portfolio_Logo Product Portfolio
PGxOne_Test_Photo Product Portfolio

PGxOne™ Plus is a comprehensive pharmacogenomics (PGx) test that predicts effective treatment and dosages. The test includes over 50 genes related to over 300 different drugs. Based off of need, different report formats are available.

Oncology_Test_Portfolio_Logo Product Portfolio
Cardiovascular_Photo Product Portfolio

Admera Health’s Oncology Test Portfolio spans the continuum of patient care. Included tests for supportive care, blood based non-invasive cancer testing, and comprehensive tumor profiling.

Cardiovascular_Test_Portfolio_Logo Product Portfolio
Oncology_Photo Product Portfolio

Admera Health’s unique Cardiovascular Test Portfolio includes a suite of tests to aid in risk assessment, diagnosis, and treatment decisions for a wide range of cardiovascular disease conditions.

Helix Store

Admera Health also provides consumer
initiated hereditary and wellness genetic
screening through the Helix store.

Learn More
Helix_Platform_photo Product Portfolio
poweredbyhelix_badge_rgb_4c_padding-2x-e1528811658857 Product Portfolio